Found: 14
Select item for more details and to access through your institution.
Revealing the impact of psychiatric comorbidities on treatment outcome in early psychosis using counterfactual model explanation.
- Published in:
- Frontiers in Psychiatry, 2023, p. 01, doi. 10.3389/fpsyt.2023.1237490
- By:
- Publication type:
- Article
Cross-disorder and disorder-specific deficits in social functioning among schizophrenia and alzheimer's disease patients.
- Published in:
- PLoS ONE, 2022, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0263769
- By:
- Publication type:
- Article
The aperiodic exponent of neural activity varies with vigilance state in mice and men.
- Published in:
- PLoS ONE, 2024, v. 19, n. 8, p. 1, doi. 10.1371/journal.pone.0301406
- By:
- Publication type:
- Article
Extreme deviations from the normative model reveal cortical heterogeneity and associations with negative symptom severity in first-episode psychosis from the OPTiMiSE and GAP studies.
- Published in:
- Translational Psychiatry, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41398-023-02661-6
- By:
- Publication type:
- Article
Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: a trial design.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cannabis Use and Symptomatic Relapse in First Episode Schizophrenia: Trigger or Consequence? Data From the OPTIMISE Study.
- Published in:
- Schizophrenia Bulletin, 2023, v. 49, n. 4, p. 903, doi. 10.1093/schbul/sbad033
- By:
- Publication type:
- Article
Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical Trial.
- Published in:
- Schizophrenia Bulletin, 2023, v. 49, n. 4, p. 893, doi. 10.1093/schbul/sbac201
- By:
- Publication type:
- Article
Symptom Remission and Brain Cortical Networks at First Clinical Presentation of Psychosis: The OPTiMiSE Study.
- Published in:
- Schizophrenia Bulletin, 2021, v. 47, n. 2, p. 444, doi. 10.1093/schbul/sbaa115
- By:
- Publication type:
- Article
PROMINENT AND PERSISTENT AUTISTIC TRAITS ARE ASSOCIATED WITH EARLY NON-REMISSION IN FIRST-EPISODE SCHIZOPHRENIA.
- Published in:
- Schizophrenia Bulletin, 2020, v. 46, p. S275, doi. 10.1093/schbul/sbaa029.677
- By:
- Publication type:
- Article
Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies—PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice.
- Published in:
- Schizophrenia Bulletin, 2020, v. 46, n. 2, p. 432, doi. 10.1093/schbul/sbz067
- By:
- Publication type:
- Article
17.1 PREDICTORS OF RELAPSE IN FIRST EPISODE PSYCHOSIS PATIENTS IN REMISSION.
- Published in:
- Schizophrenia Bulletin, 2019, v. 45, p. S115, doi. 10.1093/schbul/sbz022.065
- By:
- Publication type:
- Article
The Promise of Biological Markers for Treatment Response in First-Episode Psychosis: A Systematic Review.
- Published in:
- Schizophrenia Bulletin, 2015, v. 41, n. 3, p. 559, doi. 10.1093/schbul/sbv002
- By:
- Publication type:
- Article
The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching Antipsychotics.
- Published in:
- Schizophrenia Bulletin, 2015, v. 41, n. 3, p. 549, doi. 10.1093/schbul/sbv019
- By:
- Publication type:
- Article
Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial.
- Published in:
- BMC Psychiatry, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12888-020-02992-4
- By:
- Publication type:
- Article